In esophageal squamous cell carcinoma, non-small cell lung cancer and hepatocellular carcinoma, the level of AEG-1 upregulation also correlates with clinical progression (staging) and poor prognosis of patients [12-14], further suggesting that AEG-1 might function as an oncogenic protein in various tumor types. Here, MTDH is linked to hepatocellular carcinoma.